Wouter W van Solinge - JoVE Visualize

Showing results (31-40 of 142) with videos related to

Pageof 15

Sort By:

Blood Cells, Molecules & Diseases|February 6, 2004

Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenaseRichard van Wijk, Eric G Huizinga, Ingrid Prins, et al.

Blood Cells, Molecules & Diseases|February 25, 2005

Pyruvate kinase regulatory element 1 (PKR-RE1) mediates hexokinase gene expression in K562 cellsKaren M K de Vooght, Richard van Wijk, Brigitte A van Oirschot, et al.

Pharmacoepidemiology and Drug Safety|December 17, 2009

Measuring exacerbations in obstructive lung diseaseKarin J Velthove, Patrick C Souverein, Wouter W van Solinge, et al.

JMIR Formative Research|April 25, 2019

Measuring Free-Living Physical Activity With Three Commercially Available Activity Monitors for Telemonitoring Purposes: Validation StudyMartine Jm Breteler, Joris H Janssen, Wilko Spiering, et al.

Blood|October 24, 2002

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiencyRichard van Wijk, Wouter W van Solinge, Claus Nerlov, et al.

Respiratory Medicine|September 29, 2009

Effects of corticosteroid use on readmission in obstructive lung diseaseKarin J Velthove, Patrick C Souverein, Wouter W van Solinge, et al.

Haematologica|July 18, 2009

First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysisKaren M K de Vooght, Wouter W van Solinge, Annet C van Wesel, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2013

Automated surveillance for healthcare-associated infections: opportunities for improvementMaaike S M van Mourik, Annet Troelstra, Wouter W van Solinge, et al.

Nanomedicine (London, England)|March 30, 2016

Cetuximab treatment alters the content of extracellular vesicles released from tumor cellsSusan M van Dommelen, Roy van der Meel, Wouter W van Solinge, et al.

Journal of Extracellular Vesicles|March 17, 2016

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targetingSander A A Kooijmans, Clara Gómez Aleza, Steve R Roffler, et al.

Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:

Pageof 15

Blood Cells, Molecules & Diseases|February 6, 2004

Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenaseRichard van Wijk, Eric G Huizinga, Ingrid Prins, et al.

Blood Cells, Molecules & Diseases|February 25, 2005

Pyruvate kinase regulatory element 1 (PKR-RE1) mediates hexokinase gene expression in K562 cellsKaren M K de Vooght, Richard van Wijk, Brigitte A van Oirschot, et al.

Pharmacoepidemiology and Drug Safety|December 17, 2009

Measuring exacerbations in obstructive lung diseaseKarin J Velthove, Patrick C Souverein, Wouter W van Solinge, et al.

JMIR Formative Research|April 25, 2019

Measuring Free-Living Physical Activity With Three Commercially Available Activity Monitors for Telemonitoring Purposes: Validation StudyMartine Jm Breteler, Joris H Janssen, Wilko Spiering, et al.

Blood|October 24, 2002

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiencyRichard van Wijk, Wouter W van Solinge, Claus Nerlov, et al.

Respiratory Medicine|September 29, 2009

Effects of corticosteroid use on readmission in obstructive lung diseaseKarin J Velthove, Patrick C Souverein, Wouter W van Solinge, et al.

Haematologica|July 18, 2009

First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysisKaren M K de Vooght, Wouter W van Solinge, Annet C van Wesel, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2013

Automated surveillance for healthcare-associated infections: opportunities for improvementMaaike S M van Mourik, Annet Troelstra, Wouter W van Solinge, et al.

Nanomedicine (London, England)|March 30, 2016

Cetuximab treatment alters the content of extracellular vesicles released from tumor cellsSusan M van Dommelen, Roy van der Meel, Wouter W van Solinge, et al.

Journal of Extracellular Vesicles|March 17, 2016

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targetingSander A A Kooijmans, Clara Gómez Aleza, Steve R Roffler, et al.

Pageof 15